Registration
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement relating to plasma protein therapies; Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Orphan drug designation; patient access to therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI New | — |
Health Issues HCR
Medicare reimbursement relating to plasma protein therapies; Orphan exemption to the annual pharmaceutical fee; Orphan drug tax credit; Orphan drug designation; patient access to therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GRIFOLS S.A. | Spain | Spain | — | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.